Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Sugar.IQ(TM) now has new prediction feature for Hypoglycemia

Sugar.IQ(TM) now has new prediction feature for Hypoglycemia

15th January 2019

Medtronic, in collaboration with IBM Watson Health, have announced a new feature for their Sugar.IQ(TM) personal diabetes assistant app IQcast(TM), available on iOS-based mobile devices to users of the Medtronic Guardian(TM) Connect system in the US. It uses artificial intelligence technology from IBM Watson Health to analyse various signals to evaluate whether a diabetic has a low, medium, or high risk of going low over the next 1-4 hours.
Dr. Lisa Latts, deputy chief health officer at IBM Watson Health said: “Hypoglycaemia, or ‘going low’, is one of the most acute and frightening events that a person living with diabetes can experience. Fuelled by the right data, AI and machine learning can play a powerful role in helping to alleviate the burden of diabetes and the worry of a hypoglycaemic event, and we’ve built the new IQcast features with this goal in mind.”
Dr. Robert Vigersky, senior director, Medical & Clinical Affairs for Diabetes Group at Medtronic, said: “Simply put, IQcast acts like a weather forecast for people with diabetes so they can better prepare for their day. By predicting the likelihood of a low glucose event from anywhere between 1 and 4 hours in advance, IQcast empowers people on multiple daily injections with insights so they can live their life with greater freedom and better health.”

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.